Skip to main content
Log in

Octreotid zur Chylothoraxtherapie bei 2 Frühgeborenen

Octreotide for the treatment of chylothorax in two preterm infants

  • Kasuistiken
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

Zusammenfassung

Seit einigen Jahren wird über den Einsatz von Somatostatin (SST) bzw. dessen Analogon Octreotid (OCT) zur Behandlung des therapierefraktären Chylothorax in der Neonatalperiode berichtet. Bezüglich Indikation, Dosierung und Behandlungsdauer existieren keine allgemein anerkannten Therapieschemata. Bei den wenigen bisher berichteten Fällen des Einsatzes bei Frühgeborenen <32 SSW (Schwangerschaftswochen) kam es zu einem Sistieren des Chylusverlustes ohne schwere Nebenwirkungen. Wir beschreiben 2 Frühgeborene [GA („gestational age“) 25 und 27 SSW] mit prolongiertem Chylothorax nach Thorakotomie. Beide Kinder wurden mit OCT (96 µg/kg/Tag) behandelt.

Abstract

In recent years the use of somatostatin (SST) or its analogue octreotide (OCT) has been described for the treatment of refractory chylothorax in neonates. Indication, dose and length of treatment are not precisely defined as yet. To date only few cases of OCT or SST use in preterm infants with a gestational age <32 weeks have been published. Treatment was successful in these patients without serious adverse effects. We report two preterm (gestational age 27 and 25 weeks) infants with chylothorax following surgical ligation of a patent arterial duct. Both patients were treated successfully with OCT (96 µg/kg per day).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Allen EM, Heeckeren DW van, Spector ML, Blumer JL (1991) Management of nutritional and infectious complications of postoperative chylothorax in children. J Pediatr Surg 26:1169–1174

    Article  PubMed  CAS  Google Scholar 

  2. Büttiker V, Fanconi S, Burger R (1999) Chylothorax in children: guidelines for diagnosis and management. Chest 116:682–687

    Article  PubMed  Google Scholar 

  3. Buettiker V, Hug MI, Burger R, Baenziger O (2001) Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med 27:1083–1086

    Article  PubMed  CAS  Google Scholar 

  4. Chernick V, Reed MH (1970) Pneumothorax and chylothorax in the neonatal period. J Pediatr 76:624–632

    Article  PubMed  CAS  Google Scholar 

  5. Clarke SA, Lakhoo K, Sherwood W (2005) Somatostatin for intractable postoperative chylothorax in a premature infant. Pediatr Surg Int 21(5)390–391

    Google Scholar 

  6. Cleveland K, Zook D, Harvey K, Woods RK (2009) Massive chylothorax in small babies. J Pediatr Surg 44:546–550

    Article  PubMed  Google Scholar 

  7. Coulter DM (2004) Successful treatment with octreotide of spontaneous chylothorax in a premature infant. J Perinatol 24(3):194–195

    Article  PubMed  Google Scholar 

  8. Goto M, Kawamata K, Kitano M et al (2003) Treatment of chylothorax in a premature infant using somatostatin. J Perinatol 23:563–564

    Article  PubMed  Google Scholar 

  9. Helin RD, Angeles ST, Bhat R (2006) Octreotide therapy for chylothorax in infants and children: a brief review. Pediatr Crit Care Med 7:576–579

    Article  PubMed  Google Scholar 

  10. Landvoigt MT, Mullett CJ (2006) Octreotide efficiacy in the treatment of chylothoraces following cardiac surgery in infants and children. Pediatr Crit Care Med 7:245–248

    Article  PubMed  Google Scholar 

  11. Lauterbach R, Sczaniecka B, Koziol J, Knapczyk M (2005) Somatostatin treatment of spontaneous chylothorax in an extremely low birth weight infant. Eur J Pediatr 164:195–196

    Article  PubMed  Google Scholar 

  12. Mohseni-Bod H, Macrae D, Slavik Z (2004) Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe? Pediatr Crit Care Med 5:356–357

    Article  PubMed  Google Scholar 

  13. Rasiah SV, Oei J, Lui K (2004) Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health 40:585–588

    Article  PubMed  CAS  Google Scholar 

  14. Rocha G (2007) Pleural effusions in the neonate. Curr Opin Pulm Med 13:305–311

    Article  PubMed  Google Scholar 

  15. Rocha G, Fernandes P, Rocha P et al (2006) Pleural effusions in the neonate. Acta Paediatr 95:791–798

    Article  PubMed  Google Scholar 

  16. Röhr CC, Blank JD, Proquitte H et al (2008) Somatostatin and octreotide: treatment options for chylothorax in young children – a systematic literature review. Lymphol Forsch Prax 12:22–28

    Google Scholar 

  17. Van Aerde J, Campbell AN, Smyth JA et al (1984) Spontaneous chylothorax in newborns. Am J Dis Child 138:961–964

    Google Scholar 

  18. Van Straaten HL, Gerards LJ, Krediet TG (1993) Chylothorax in the neonatal period. Eur J Pediatr 152:2–5

    Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Haase.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haase, R., Lieser, U., Buttenhoff, S. et al. Octreotid zur Chylothoraxtherapie bei 2 Frühgeborenen. Monatsschr Kinderheilkd 159, 364–367 (2011). https://doi.org/10.1007/s00112-010-2358-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-010-2358-2

Schlüsselwörter

Keywords

Navigation